SIRION Biotech GmbH is a leading commercial supplier of viral vector technologies (AAV, LV, AV). Our viral vector experience and know-how is applied to engineering a new generation of optimized vectors.
We guide our clients through the entire Cell & Gene Therapy value chain:
Capsid evolution and clinical vector design to reduce vector dose and improve therapeutic success
Process and development experience for individual optimization
Individual support and project planning with expert managers
Manufacture of high-quality, clinically optimized viral vectors for late preclinical applications.
We also offer LentiBOOST®, a highly effective lentiviral transduction enhancer for therapeutic cell types such as CAR-T cells and CD34+ hematopoietic stem cells. LentiBOOST is currently included in more than 40 Phase III and I/II clinical trials and also one approved cell therapy medication.
SIRION is located near Munich with additional labs in Heidelberg, and sales offices in Paris and Boston.